Joe Palandra

Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse

Hani Zaher, Anis A. Khan, Joe Palandra et al. · Molecular Pharmaceutics · 2006 · 159 citations

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Bradley L. Urquhart, Joseph A. Ware, Rommel G. Tirona et al. · Pharmacogenetics and Genomics · 2008 · 138 citations · Full text

Breast Oncology, Drug Disposition, Pathology +18

Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin

Hani Zaher, Henriette E. Meyer zu Schwabedissen, Rommel G. Tirona et al. · Molecular Pharmacology · 2008 · 118 citations · Full text

Highly Specific and Sensitive Measurements of Human and Monkey Interleukin 21 Using Sequential Protein and Tryptic Peptide Immunoaffinity LC-MS/MS

Joe Palandra, Alyce L. Finelli, Ming Zhu et al. · Analytical Chemistry · 2013 · 105 citations

Laboratory Immunology, Immunodeficiencies, Immunology +16

LC−MS/MS Mediated Absolute Quantification and Comparison of Bile Salt Export Pump and Breast Cancer Resistance Protein in Livers and Hepatocytes across Species

Na Li, Joe Palandra, Olga V. Nemirovskiy et al. · Analytical Chemistry · 2009 · 100 citations

Immunology, Pathology, Cholangiopathies +21